Replies to post #4828 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

Profitability is a few quarters away. In the Investor Day PR, RVNC implicitly guided that it won't be profitable on an EBITDA basis during 2024 as a whole (#msg-172850997), although EBITDA profitability could happen in 4Q24. RVNC has not guided for when it expects profitability on a GAAP basis.